Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
Venova Medical develops the Velocity percutaneous arteriovenous fistula system, a minimally invasive medical device designed to create vascular access for hemodialysis patients more efficiently than traditional surgical methods. The system addresses barriers to AVF creation and maturation, targeting patients with chronic kidney disease who require dialysis access.
2 investors
Vensica is a clinical-stage medical company developing ViXe, a needle-free treatment for overactive bladder that combines the neurotoxin Xeomin with Vibe, an ultrasound-based drug delivery device that microinjects medication into the bladder wall. The company focuses on urology therapeutics for unmet medical needs.
2 investors
Veracyte develops genomic diagnostic tests for cancer, offering laboratory developed tests for thyroid, prostate, bladder, and breast cancers performed in its CLIA-certified, high-complexity labs. Its tests analyze each patient's tumor biology to help clinicians make personalized treatment decisions.
2 investors
Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery. The company's lead program, abenacianine for injection, is in Phase 2b clinical evaluation for lung cancer surgery applications.
2 investors
Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.
2 investors
VerImmune develops immunotherapy medicines that redirect pre-existing immune memory toward cancer cells to achieve tumor destruction with low toxicity. The company targets cancer patients across a broad range of cancer types.
2 investors
Verinnogen develops data collection technology for pre-clinical cancer research, aiming to improve the accuracy, repeatability, and reliability of research data. The company draws on expertise in cancer biology and medical device development.
2 investors
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings. The company focuses on designing and commercializing innovative medical devices to address unmet clinical needs.
2 investors
Versa Vascular is developing a tricuspid valve repair device with a delivery system designed for precise, repositionable implant placement. The company operates in the medical device sector.
2 investors
Vertero develops therapies for neurodegenerative diseases by targeting causative mechanisms in the peripheral nervous system rather than addressing symptoms alone. The company uses discoveries in microbiology, pharmacology, and neuroscience to create novel drug treatments for patients with unmet needs.
2 investors
Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease. The devices are intended for physicians treating patients with deep venous disease, positioning the company in the vascular medical device space.
2 investors
Vessi Medical develops a minimally invasive cryo spray system for treating urological conditions in the bladder, offering a non-surgical alternative to traditional procedures performed in hospital settings. The system enables office-based treatment without anesthesia in some cases, reducing complications and healthcare costs compared to conventional surgical approaches.
2 investors
Vessl designs adaptive prosthetic technology that adjusts to the body's dynamic changes to provide consistent comfort and natural movement for amputees. The company's Kinn™ system is engineered to function seamlessly in daily life without requiring constant adjustments.
2 investors
Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.
2 investors
ViaNautis develops targeted polyNaut nanovesicle (tPNV) delivery technology to advance cell and gene therapies and genetic medicines. A UCL spin-out originally established as SomaServe in 2018, the company operates from facilities in Cambridge, UK.
2 investors
Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
2 investors
Vibrant Gastro develops a drug-free medical device using micro-vibrations to treat chronic idiopathic constipation in adults. The company's Vibrant System employs the Synchronized Activation Method to mechanically stimulate the colon and improve natural bowel motility.
2 investors
Vicarious Surgical develops a surgical robot for minimally invasive laparoscopic procedures, providing surgeons with 3D visualization and precise control. The system, which has received FDA Breakthrough Device Designation, targets hospitals, surgeons, and patients seeking advanced surgical care.
2 investors
ViewMind develops technology that provides objective, measurable data about brain function under cognitive stress to support clinical evaluation. The company's solution complements traditional biomarkers and imaging for healthcare providers.
2 investors
ViewRay develops MRIdian A3i, an MRI-guided radiation therapy system that uses diagnostic-quality MRI imaging for real-time tissue tracking and automated beam control during cancer treatment. The system is used by hospitals and cancer centers to treat pancreas, prostate, lung, liver, breast, and oligometastatic cancers.
2 investors
ViroCarb is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its leadership brings experience in early-stage biopharma, medical devices, and industrial R&D.
2 investors
VISIE develops computer vision systems for surgical robotics that enable real-time visual tracking of patient anatomy without requiring reference pins or arrays. The technology is designed for orthopedic robot manufacturers to integrate into navigation systems for surgical procedures.
2 investors
Vista AI develops software that automates MRI image acquisition to enable clinicians to perform high-quality cardiac scans quickly and consistently. The company plans to expand its AI-driven technology to cover brain, prostate, spine, and other anatomical areas.
2 investors
Vistim is a company leveraging neuroscience and artificial intelligence to develop solutions in the healthcare and medical technology space, drawing on expertise from neurology, brain-computer interfaces, EEG manufacturing, and pharmaceutical development.
2 investors